Child with atopic dermatitis

Annals of Allergy, Asthma and Immunology

Volumn 114, Issue 1, 2015, Pages 6-11

  Kanchongkittiphon, Watcharoot ^a,b,c   Gaffin, Jonathan M ^a,b   Phipatanakul, Wanda ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN A; IMMUNOGLOBULIN E; IMMUNOMODULATING AGENT; METHOTREXATE; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OMALIZUMAB; RITUXIMAB; STEROID; VITAMIN D; CYCLOSPORIN; HOUSE DUST ALLERGEN; TACROLIMUS;

ATOPIC DERMATITIS; BATH; BLEACH BATH; CASE REPORT; CHILD; DISEASE ASSOCIATION; ECZEMA; EPIDERMIS; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; LABORATORY TEST; MALE; PATHOGENESIS; PATIENT EDUCATION; PHOTOTHERAPY; PHYSICAL EXAMINATION; REVIEW; SCHOOL CHILD; SEASONAL VARIATION; SKIN EXAMINATION; SLEEP DISORDER; SUBCUTANEOUS IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY; SYSTEMATIC REVIEW; TREATMENT INDICATION; ANIMAL; BLOOD; DERMATITIS, ATOPIC; DESENSITIZATION; EDEMA; IMMUNOLOGY; PRESCHOOL CHILD; PROCEDURES; PYROGLYPHIDAE; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DERMATITIS, ATOPIC; DESENSITIZATION, IMMUNOLOGIC; ECZEMA; EDEMA; HUMANS; IMMUNOGLOBULIN E; MALE; PYROGLYPHIDAE; TACROLIMUS;

EID: 84918787572     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2014.08.016     Document Type: Review

References (38)

1. Williams HC. Clinical practice. Atopic dermatitis. N Engl J Med. 2005;352: 2314-2324.
2. Calabria C, Commins S, Gerrish P, et al. Hypersensitivity Disorders. Arlington Heights, IL: American College of Allergy, Asthma & Immunology; 2010.
3. Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. J Invest Dermatol. 2011;131:67-73.
4. Peters AS, Kellberger J, Vogelberg C, et al. Prediction of the incidence, recurrence, and persistence of atopic dermatitis in adolescence: a prospective cohort study. J Allergy Clin Immunol. 2010;126:590-595. e1-3.
5. Leung DYM, Eichenfield LF, Boguniewicz M. Atopic dermatitis (atopic eczema). In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, eds. Fitzpatrick's Dermatology in General Medicine. 7th ed, Vol. 1. New York: McGraw-Hill; 2008:146-158.
6. Sicherer SH, Leung DY. Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2013. J Allergy Clin Immunol. 2014;133:324-334.
7. Sprecher E, Leung DY. Atopic dermatitis: scratching through the complexity of barrier dysfunction. J Allergy Clin Immunol. 2013;132:1130-1131.
8. Rodriguez E, Baurecht H, Herberich E, et al. Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J Allergy Clin Immunol. 2009;123:1361-1370.e7.
9. Gao PS, Rafaels NM, Hand T, et al. Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum. J Allergy Clin Immunol. 2009;124:507-513. e1-7.
10. Ziegler SF. Thymic stromal lymphopoietin and allergic disease. J Allergy Clin Immunol. 2012;130:845-852.
11. De Benedetto A, Rafaels NM, McGirt LY, et al. Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol. 2011;127:773-786. e1-7.
12. Simon D, Kernland Lang K. Atopic dermatitis: from new pathogenic insights toward a barrier-restoring and anti-inflammatory therapy. Curr Opin Pediatr. 2011;23:647-652.
13. Cornelissen C, Marquardt Y, Czaja K, et al. IL-31 regulates differentiation and filaggrin expression in human organotypic skin models. J Allergy Clin Immunol. 2012;129:426-433. e1-8.
14. Nograles KE, Zaba LC, Shemer A, et al. IL-22eproducing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17eproducing TH17 T cells. J Allergy Clin Immunol. 2009;123:1244-1252.e2.
15. Rork JF, Sheehan WJ, Gaffin JM, et al. Parental response to written eczema action plans in children with eczema. Arch Dermatol. 2012;148:391-392.
16. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology. 1993;186:23-31.
17. Schneider L, Tilles S, Lio P, et al. Atopic dermatitis: a practice parameter update 2012. J Allergy Clin Immunol. 2013;131:295-299. e1-27.
18. Ring J, Alomar A, Bieber T, et al. Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol. 2012;26:1045-1060.
19. Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71:116-132.
20. Sidbury R, Davis DM, Cohen DE, et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014;71:327-349.
21. Ference JD, Last AR. Choosing topical corticosteroids. Am Fam Phys. 2009;79: 135-140.
22. Huang JT, Abrams M, Tlougan B, Rademaker A, Paller AS. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics. 2009;123:e808ee814.
23. Wong SM, Ng TG, Baba R. Efficacy and safety of sodium hypochlorite (bleach) baths in patients with moderate to severe atopic dermatitis in Malaysia. J Dermatol. 2013;40:874-880.
24. Kaplan SL, Forbes A, Hammerman WA, et al. Randomized trial of "bleach baths" plus routine hygienic measures vs. routine hygienic measures alone for prevention of recurrent infections. Clin Infect Dis. 2014;58:679-682.
25. Nizet V, Ohtake T, Lauth X, et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature. 2001;414:454-457.
26. Peroni DG, Piacentini GL, Cametti E, Chinellato I, Boner AL. Correlation between serum 25-hydroxyvitamin D levels and severity of atopic dermatitis in children. Br J Dermatol. 2011;164:1078-1082.
27. Mutgi K, Koo J. Update on the role of systemic vitamin D in atopic dermatitis. Pediatr Dermatol. 2013;30:303-307.
28. Clayton TH, Clark SM, Turner D, Goulden V. The treatment of severe atopic dermatitis in childhood with narrowband ultraviolet B phototherapy. Clin Exp Dermatol. 2007;32:28-33.
29. Compalati E, Rogkakou A, Passalacqua G, Canonica GW. Evidences of efficacy of allergen immunotherapy in atopic dermatitis: an updated review. Curr Opin Allergy Clin Immunol. 2012;12:427-433.
30. Cox L. Sublingual immunotherapy for aeroallergens: status in the United States. Allergy Asthma Proc. 2014;35:34-42.
31. Cox L, Nelson H, Lockey R, et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol. 2011;127(suppl):S1eS55.
32. Bae JM, Choi YY, Park CO, Chung KY, Lee KH. Efficacy of allergen-specific immunotherapy for atopic dermatitis: a systematic review and metaanalysis of randomized controlled trials. J Allergy Clin Immunol. 2013;132: 110-117.
33. Werfel T, Breuer K, Rueff F, et al. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, doseeresponse study. Allergy. 2006;61: 202-205.
34. Heil PM, Maurer D, Klein B, Hultsch T, Stingl G. Omalizumab therapy in atopic dermatitis: depletion of IgE does not improve the clinical courseda randomized, placebo-controlled and double blind pilot study. J Dtsch Dermatol Ges. 2010;8:990-998.
35. Gauvreau GM, O'Byrne PM, Boulet LP, et al. Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. N Engl J Med. 2014;370:2102-2110.
36. Simon D, Hosli S, Kostylina G, Yawalkar N, Simon HU. Anti-CD20 (rituximab) treatment improves atopic eczema. J Allergy Clin Immunol. 2008;121: 122-128.
37. Sediva A, Kayserova J, Vernerova E, et al. Anti-CD20 (rituximab) treatment for atopic eczema. J Allergy Clin Immunol. 2008;121:1515-1516. author reply 6-7.
38. Beck LA, Thaci D, Hamilton JD, et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N Engl J Med. 2014;371:130-139.